<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>PROFID Project</title>

  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700&display=swap" rel="stylesheet">

  <style>
    :root {
      --primary: #0b4fa2;
      --secondary: #e6eef8;
      --text: #1f2937;
      --muted: #6b7280;
      --max-width: 1100px;
    }

    * {
      box-sizing: border-box;
    }

    body {
      margin: 0;
      font-family: "Inter", sans-serif;
      color: var(--text);
      line-height: 1.6;
      background: #ffffff;
    }

    header {
      background: linear-gradient(135deg, #0b4fa2, #083b78);
      color: white;
      padding: 4rem 1.5rem;
    }

    .container {
      max-width: var(--max-width);
      margin: auto;
    }

    .hero {
      display: grid;
      grid-template-columns: 1.2fr 0.8fr;
      gap: 3rem;
      align-items: center;
    }

    .hero img {
      max-width: 100%;
      border-radius: 12px;
      background: white;
      padding: 1rem;
    }

    h1 {
      font-size: 2.4rem;
      margin-bottom: 1rem;
    }

    h2 {
      font-size: 1.8rem;
      margin-bottom: 1rem;
      color: var(--primary);
    }

    h3 {
      margin-top: 0;
      color: var(--primary);
    }

    .subtitle {
      font-size: 1.1rem;
      color: #e5edfa;
    }

    section {
      padding: 4rem 1.5rem;
    }

    .intro {
      background: var(--secondary);
    }

    .phases {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
      gap: 2rem;
      margin-top: 2rem;
    }

    .card {
      background: white;
      padding: 2rem;
      border-radius: 12px;
      box-shadow: 0 10px 25px rgba(0,0,0,0.06);
    }

    ul {
      padding-left: 1.2rem;
    }

    .studies li {
      margin-bottom: 0.6rem;
    }

    .logos {
      display: flex;
      gap: 2rem;
      flex-wrap: wrap;
      justify-content: center;
      align-items: center;
      margin-top: 2rem;
    }

    .logos img {
      max-height: 70px;
      opacity: 0.85;
    }

    footer {
      background: #0f172a;
      color: #cbd5e1;
      padding: 3rem 1.5rem;
      font-size: 0.9rem;
    }

    footer a {
      color: #93c5fd;
      text-decoration: none;
    }

    @media (max-width: 900px) {
      .hero {
        grid-template-columns: 1fr;
      }
    }
  </style>
</head>

<body>

<header>
  <div class="container hero">
    <div>
      <h1>Prevention of Sudden Cardiac Death after Myocardial Infarction</h1>
      <p class="subtitle">
        Reassessing prophylactic ICD implantation under contemporary optimal medical therapy
      </p>
    </div>
    <img src="assets/image1.jpg" alt="PROFID Project Logo">
  </div>
</header>

<section class="intro">
  <div class="container">
    <h2>About PROFID</h2>
    <p>
      The ambition of PROFID is to reassess the role of routine prophylactic ICD implantation
      in patients with reduced LVEF ≤ 35% after myocardial infarction under contemporary
      optimal medical therapy (OMT).
    </p>
    <p>
      By fundamentally improving clinical practice, PROFID aims to substantially reduce
      the enormous burden that sudden cardiac death places on both society and individual patients.
    </p>
  </div>
</section>

<section>
  <div class="container">
    <h2>Project Phases</h2>

    <div class="phases">
      <div class="card">
        <h3>Data Analysis</h3>
        <p>
          PROFID analyses highly phenotyped data from approximately 200,000 post-myocardial
          infarction patients across national registries, institutional databases, EHRs and claims data.
        </p>
        <p>
          This repository contains analytical pipelines used to conduct cohort studies within
          the PROFID data lake, planned for publication in 2026.
        </p>
      </div>

      <div class="card">
        <h3>Clinical Trial</h3>
        <p>
          A non-inferiority randomised clinical trial comparing optimal medical therapy alone
          versus ICD implantation plus OMT in post-MI patients with LVEF ≤ 35%.
        </p>
        <p>
          The goal is to optimise patient selection for ICD therapy while maintaining safety.
        </p>
      </div>
    </div>
  </div>
</section>

<section class="intro">
  <div class="container">
    <h2>Research Studies</h2>
    <ul class="studies">
      <li>Inappropriate ICD Therapy and Mortality (N. Girkar)</li>
      <li>Seasonal Patterns in SCD Incidence (A. Sampri)</li>
      <li>ICD Shock Rates Analysis (I. Verdun)</li>
      <li>Age-Stratified SCD Incidence (A. Boudamaana)</li>
      <li>Heart Failure Therapy Adherence (A. Boudamaana)</li>
      <li>BMI and Sudden Cardiac Death (C. Coffey)</li>
      <li>Geographic Disparities in SCD (M. Jain)</li>
      <li>SCD Risk Stratification in AF Patients (H. Raza)</li>
      <li>Temporal Trends in SCD (A. Boudamaana)</li>
    </ul>
  </div>
</section>

<section>
  <div class="container">
    <h2>Publications</h2>
    <p>TBA</p>

    <div class="logos">
      <img src="assets/image2.png" alt="Partner logo">
      <img src="assets/image3.jpg" alt="Partner logo">
    </div>
  </div>
</section>

<footer>
  <div class="container">
    <p>
      Technical support: please raise issues directly in this repository.
      <br>
      Academic inquiries: contact the corresponding authors of published studies.
    </p>
    <p>
      © PROFID Project • MIT License
    </p>
  </div>
</footer>

</body>
</html>
